Pharma Patent Ruling Pinches Opportunities in Emerging Markets
The decision by an Indian court not to grant a new patent to Novartis for a modified form of its cancer drug Glivec was a heavy blow to the company.
Philanthropy Focus: Page Snow on Advisors and 'Impact' Investing
If you want wealthy clients, learn about a new trend of mission-related investments. Page Eberstadt Snow, Foundation Source's chief philanthropic officer, says private foundations are judging advisors by their expertise in this area.